Sara Marsal graduated in Medicine and Surgery from Navarra University in 1985, after which she completed her Ph.D. at Barcelona University in 1990. She was a Rheumatology Resident at the Vall d'Hebron University Hospital, Barcelona (1991-1994). In 2000, she started the Rheumatology Research Group in Vall Hebron University Hospital (HUVH), a translational research lab on immune-mediated inflammatory diseases (IMIDs). Since 2012, she has been an Associate Professor of Rheumatology at the Universitat Autònoma de Barcelona, Barcelona, Spain. She is currently the head of the Rheumatology Department at the HUVH. She has performed pioneering studies in the genomics of IMIDs that have been published in top-tier journals in biomedical research. Using high-throughput molecular analysis approaches, she has identified new molecular profiles associated with diagnosis and treatment response in this group of diseases. Since 2006, she has been the director of the IMID Consortium, a network of 90 reference clinical researchers in rheumatology, dermatology and gastroenterology that is devoted to the discovery of new clinically useful biomarkers through multi-omics approaches. She also directs the IMID-Biobank, a large unique sample collection of >15,000 patients from the most prevalent autoimmune diseases. She serves on a variety of advisory panels from the pharmacological and biotechnological sectors. She is also a founder and science advisor of IMIDomics, Inc.
